Francesca Gatti

ORCID: 0009-0000-1605-7755
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • SARS-CoV-2 detection and testing
  • Toxoplasma gondii Research Studies
  • Hemoglobinopathies and Related Disorders
  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • interferon and immune responses
  • Long-Term Effects of COVID-19
  • Adenosine and Purinergic Signaling
  • COVID-19 epidemiological studies
  • Liver Disease Diagnosis and Treatment
  • Trauma and Emergency Care Studies
  • Biochemical and Molecular Research
  • Signaling Pathways in Disease
  • Pancreatic function and diabetes
  • Telemedicine and Telehealth Implementation
  • Educational and Social Studies
  • Telomeres, Telomerase, and Senescence
  • Immune cells in cancer
  • Ocular Diseases and Behçet’s Syndrome
  • Cannabis and Cannabinoid Research
  • Autophagy in Disease and Therapy
  • Italian Social Issues and Migration

University of Bari Aldo Moro
2025

AULSS 2 Marca Trevigiana
2021-2024

Casa Sollievo della Sofferenza
2023

University of Brescia
2010-2023

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2010-2023

University of Padua
2021-2022

Azienda Ospedaliera Universitaria Senese
2021

University of Siena
2021

Brescia University
2020

Harvard University
2013-2015

Age is a major risk factor in age-related macular degeneration (AMD), but the underlying cause unknown. We find increased Rho-associated kinase (ROCK) signaling and M2 characteristics eyes of aged mice, revealing immune changes aging. ROCK isoforms determine macrophage polarization into M1 subtypes. M2-like macrophages accumulated AMD, not normal eyes, suggesting that these may be linked to degeneration. injected mouse eye exacerbated choroidal neovascular lesions, while ameliorated them,...

10.1016/j.celrep.2015.01.050 article EN cc-by-nc-nd Cell Reports 2015-02-01

The lymphocytic ionotropic purinergic P2X receptors (P2X1R-P2X7R, or P2XRs) sense ATP released during cell damage-activation, thus regulating T-cell activation. We aim to define the role of P2XRs islet allograft rejection and establish a novel anti-P2XRs strategy achieve long-term function. Our data demonstrate that P2X1R P2X7R are induced in allograft-infiltrating cells, only is increasingly expressed alloimmune response, augmented both allogeneic syngeneic transplantation. In vivo...

10.2337/db12-0242 article EN cc-by-nc-nd Diabetes 2013-01-12

This study aimed to describe the longitudinal evolution of neutralizing antibody titres (NtAb) in three different cohorts healthcare workers (HCWs), including vaccinated HCWs with and without a previous SARS-CoV-2 infection previously infected unvaccinated HCWs. COVID-19 was mild or asymptomatic those experiencing infection.NtAb tested before BNT162b2 mRNA vaccine (V0), 20±2 days after first dose (V1_20), 20±3 (V2_20) 90±2 (V2_90) second about 2 months (N_60), 10 (N_300) 13 (N_390) from...

10.1016/j.ijid.2021.08.052 article EN cc-by-nc-nd International Journal of Infectious Diseases 2021-09-02

ObjectivesTo measure SARS-CoV-2 neutralizing antibody (NtAb) titres in previously infected or uninfected health care workers who received one two doses of BNT162b2 mRNA COVID-19 vaccine.MethodsNtAbs were titrated as dose-inhibiting 50% virus replication (ID50) by live microneutralization. We evaluated 41 recovering from mild asymptomatic infection at first vaccination dose (T1_inf) and 21 days later (T2_inf). Sixteen 20 after (T2_uninf) second vaccine (T3_uninf).ResultsAt T2_inf, but not...

10.1016/j.ijid.2021.05.033 article EN cc-by-nc-nd International Journal of Infectious Diseases 2021-05-19

The optimal treatment of a severe hemodynamic instability from shock to cardiac arrest in late term pregnant women is subject ongoing studies. However, there an increasing evidence that early "separation" between the mother and foetus may increase restoration status and, setting, it raise likelihood return spontaneous circulation (ROSC) mother. This treatment, called Perimortem Cesarean Section (PMCS), now termed as Resuscitative Hysterotomy (RH) better address issue section (C-section)....

10.1155/2014/121562 article EN cc-by Case Reports in Emergency Medicine 2014-01-01
Laura Bergantini Margherita Baldassarri Miriana d’Alessandro Giulia Brunelli Gaia Fabbri and 95 more Kristina Zguro Andrea Degl’Innocenti Francesca Mari Sergio Daga Ilaria Meloni Mirella Bruttini Susanna Croci Mirjam Lista Debora Maffeo Elena Pasquinelli Viola Bianca Serio E. Antolini Simona Letizia Basso Samantha Minetto Rossella Tita Maria Antonietta Mencarelli Caterina Lo Rizzo Anna Maria Pinto Francesca Ariani Francesca Montagnani Mario Tumbarello Ilaria Rancan Massimiliano Fabbiani Paolo Cameli David Bennett Federico Anedda Simona Marcantonio Sabino Scolletta Federico Franchi Maria Antonietta Mazzei Susanna Guerrini Edoardo Conticini Luca Cantarini Bruno Frediani Danilo Tacconi Chiara Spertilli Raffaelli Arianna Emiliozzi Marco Feri Alice Donati Raffaele Scala Luca Guidelli Genni Spargi Marta Corridi Cesira Nencioni Leonardo Croci Gian Piero Caldarelli Davide Romani Paolo Piacentini Maria Bandini Elena Desanctis Silvia Cappelli Anna Canaccini Agnese Verzuri Valentina Anemoli Manola Pisani Agostino Ognibene Maria Lorubbio Alessandro Pancrazzi Massimo Vaghi Antonella d’Arminio Monforte Federica Gaia Miraglia Mario U. Mondelli Stefania Mantovani Raffaele Bruno Marco Vecchia Marcello Maffezzoni Enrico Martinelli Massimo Girardis Stefano Busani Sophie Venturelli Andrea Cossarizza Andrea Antinori Alessandra Vergori Stefano Rusconi Matteo Siano Arianna Gabrieli Agostino Riva Daniela Francisci Elisabetta Schiaroli Carlo Pallotto Saverio Giuseppe Parisi Monica Basso Sandro Panese Stefano Baratti Pier Giorgio Scotton Francesca Andretta Mario Giobbia Renzo Scaggiante Francesca Gatti Francesco Castelli Eugenia Quirós-Roldán Melania Degli Antoni Isabella Zanella Matteo Della Monica Carmelo Piscopo

Abstract Background Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel coronavirus that caused an ongoing pandemic of pathology termed Disease 19 (COVID-19). Several studies reported both COVID-19 and RTEL1 variants are associated with shorter telomere length, but direct association between the two not generally acknowledged. Here we demonstrate up to 8.6% severe patients bear ultra-rare variants, show how this subgroup can be recognized. Methods A cohort 2246...

10.1186/s12931-023-02458-7 article EN cc-by Respiratory Research 2023-06-16
Francesca Minnai Filippo Biscarini Martina Esposito Tommaso A. Dragani Luís Bujanda and 95 more Souad Rahmouni Marta E. Alarcón‐Riquelme David Bernardo Elena Carnero‐Montoro Marı́a Buti Hugo Zeberg Rosanna Asselta Manuel Romero‐Gómez Francesca Mari Sergio Daga Ilaria Meloni Giulia Brunelli Mirjam Lista Debora Maffeo Elena Pasquinelli E. Antolini Simona Letizia Basso Samantha Minetto Giulia Rollo Angela Rina Martina Rozza Rossella Tita Maria Antonietta Mencarelli Caterina Lo Rizzo Anna Maria Pinto Francesca Ariani Francesca Montagnani Mario Tumbarello Ilaria Rancan Massimiliano Fabbiani Paolo Cameli David Bennett Federico Anedda Simona Marcantonio Sabino Scolletta Federico Franchi Maria Antonietta Mazzei Susanna Guerrini Edoardo Conticini Luca Cantarini Bruno Frediani Danilo Tacconi Chiara Spertilli Raffaelli Arianna Emiliozzi Marco Feri Alice Donati Raffaele Scala Luca Guidelli Genni Spargi Marta Corridi Cesira Nencioni Leonardo Croci Gian Piero Caldarelli Davide Romani Paolo Piacentini Maria Bandini Elena Desanctis Silvia Cappelli Anna Canaccini Agnese Verzuri Valentina Anemoli Agostino Ognibene Maria Lorubbio Alessandro Pancrazzi Massimo Vaghi Antonella d’Arminio Monforte Federica Gaia Miraglia Mario U. Mondelli Stefania Mantovani Raffaele Bruno Marco Vecchia Marcello Maffezzoni Enrico Martinelli Massimo Girardis Stefano Busani Sophie Venturelli Andrea Cossarizza Andrea Antinori Alessandra Vergori Stefano Rusconi Matteo Siano Arianna Gabrieli Agostino Riva Daniela Francisci Elisabetta Schiaroli Carlo Pallotto Saverio Giuseppe Parisi Monica Basso Sandro Panese Stefano Baratti Pier Giorgio Scotton Francesca Andretta Mario Giobbia Renzo Scaggiante Francesca Gatti

Abstract The clinical manifestations of SARS-CoV-2 infection vary widely among patients, from asymptomatic to life-threatening. Host genetics is one the factors that contributes this variability as previously reported by COVID-19 Genetics Initiative (HGI), which identified sixteen loci associated with severity. Herein, we investigated genetic determinants mortality, performing a case-only genome-wide survival analysis, 60 days after infection, 3904 patients GEN-COVID and other European...

10.1038/s41598-024-53310-x article EN cc-by Scientific Reports 2024-02-06

The role of the novel costimulatory molecule TIM4 in anti-islet response is unknown. We explored expression and targeting Th1 (BALB/c islets into C57BL/6 mice) Th2 Tbet(-/-) models alloimmune a model autoimmune (diabetes onset NOD mice). TIM4, using monoclonal antibody RMT4-53, promotes islet graft survival model, with 30% surviving long term; protection appears to be mediated by skewing immune response. Differently, precipitates rejection further enhancing effect anti-TIM4 treatment...

10.3727/096368914x678571 article EN Cell Transplantation 2014-03-12

10.1007/s10072-020-04666-1 article EN other-oa Neurological Sciences 2020-08-27

We describe the time course of neutralizing antibody (NtAb) titer in a cohort health care workers with mild or asymptomatic severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection. NtAb levels decreased over time; however, serum activity remained detectable after median 7 months from SARS-CoV-2 diagnosis majority cases.

10.1093/ofid/ofab312 article EN cc-by-nc-nd Open Forum Infectious Diseases 2021-06-12

We report the time course of neutralizing antibody (NtAb) response, as measured by authentic virus neutralization, in healthcare workers (HCWs) with a mild or asymptomatic SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection diagnosed at onset pandemic, no reinfection throughout and after three-dose schedule BNT162b2 mRNA vaccine an overall follow-up almost two years since infection. Forty-eight HCWs (median age 47 years, all immunocompetent) were evaluated: 29 (60.4%)...

10.3390/vaccines10081237 article EN cc-by Vaccines 2022-08-02

This study aims to assess the effect of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor (ARBs) on course COVID-19. It is a prospective 221 (M/F ratio= 143/78, mean age 72±13) consecutive hypertensive patients with COVID-19: 76 (34.4%) treated ACEIs, 63 (28.5%) ARBs 82 (37.1%) antihypertensives OTHER than ACEIs or ARBs. They were all followed up until discharge death. BAD outcome was defined as need for invasive mechanical ventilation The three classes medication...

10.4081/itjm.2020.1313 article EN cc-by-nc Italian Journal of Medicine 2020-09-18

We described the long-term decay of neutralizing antibody (NtAb) to wild-type and Delta SARS-CoV-2 variant after three antigen stimulations (mild or asymptomatic natural infection followed by two doses BNT162b2 mRNA vaccine a median 296 days) in immunocompetent healthcare workers (HCWs). Live virus microneutralization against B.1 variants was performed VERO E6 cell cultures. The NtAb titers for were comparable highly correlated at both 20 200 days second dose 23 HCWs enrolled (median age, 46...

10.3390/vaccines10040580 article EN cc-by Vaccines 2022-04-09

We aimed to investigate neutralizing antibody titers (NtAbT) the P.1 and B.1 SARS-CoV-2 variants in a cohort of healthy health care workers (HCW), including 20 previously infected individuals tested at baseline (BLinf, after median 298 days from diagnosis) 21 receiving one vaccine dose (D1inf) 15 uninfected subjects second-dose vaccination (D2uninf). All received BNT162b2 vaccination. D1inf NtAbT increased significantly with respect BLinf against both variants, fold-change higher for P.1....

10.3390/life11090896 article EN cc-by Life 2021-08-29

10.1016/s1569-1993(09)60228-9 article EN publisher-specific-oa Journal of Cystic Fibrosis 2009-06-01
Coming Soon ...